Root Financial Partners
XENE icon

Root Financial Partners’s Xenon Pharmaceuticals XENE Stock Holding History

Root Financial Partners’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.49K Buy
+40
New +$2.38K ﹤0.01% 2775
2026
Q2 		– Sell
-40
Closed -$2.33K – 3217
2026
Q1 		$2.33K Buy
+40
New +$1.84K ﹤0.01% 2254

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return

Root Financial Partners's XENE Position: Q3 2026 in Review

Root Financial Partners opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 40 shares worth $1.49K. The stake represents ﹤0.01% of the portfolio and ranks #2775 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in XENE as recently as Q1 2026.

Root Financial Partners first reported a position in XENE in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.33K in Q1 2026. 196 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Root Financial Partners held 40 shares of Xenon Pharmaceuticals worth $1.49K as of Q3 2026.
  • Xenon Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Xenon Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2775 holding.
  • Root Financial Partners first reported a position in Xenon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Root Financial Partners's Xenon Pharmaceuticals position peaked at $2.33K in Q1 2026.
  • 196 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.